Parasitology identification encompasses the process of identifying parasites through various techniques such as microscopic examination, serological tests, and molecular methods like PCR. One major application of this field lies in healthcare, where accurate identification aids in diagnosing and treating parasitic infections in humans and animals. It enables healthcare providers to prescribe appropriate medications and develop effective treatment plans. Moreover, in public health, it facilitates the identification of parasitic diseases in populations, allowing for targeted intervention and control measures, as well as monitoring the prevalence and spread of infections through surveillance programs. This comprehensive approach contributes significantly to disease management and prevention efforts.
The Global Parasitology Identification Market valued at USD 4,092.15 million in 2022 is projected to reach USD 6,522.27 million by 2030 and will grow at a CAGR of 6% during the forecast period of 2023-2030.
Below are the Top Parasitology Identification companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
BIOMÉRIEUX
|
A leading player in the Parasitology Identification Market, BIOMÉRIEUX offers a range of diagnostic solutions, including molecular assays and automated systems for detecting parasitic infections. Their products are known for their accuracy and efficiency, aiding healthcare providers in timely diagnosis and treatment.
|
|
Europe, North America, South America, Middle East and Africa, and Asia-Pacific
|
In September 2014, bioMeriuex SA launched chromID, Salmonella Culture media for rapid detection of salmonella in stool samples. This will help in generating more revenue and Portfolio of the company and helped in serving more customers.
|
|
2.
|
Abbott
|
Abbott is a key player in the Parasitology Identification Market, providing innovative diagnostic tests and platforms for detecting a wide range of parasites. Their portfolio includes rapid diagnostic tests (RDTs) and molecular assays, empowering clinicians with reliable tools for identifying parasitic infections swiftly.
|
|
Europe, North America, South America, Middle East and Africa, and Asia-Pacific
|
In August 2020, a malaria study was conducted in the Mpigi district using Abbott Laboratories' latest rapid diagnostic malaria kit and the normal test that is currently running in the market. Some breakthrough results came, such as double the positivity rate in Abbott's rapid diagnostic test compared to the normal one. With this, the company has enhanced its brand value in the market.
|
|
3.
|
Bruker
|
Bruker is recognized for its advanced technologies in the Parasitology Identification Market, offering mass spectrometry-based solutions for parasite identification. Their systems provide high sensitivity and specificity, enabling precise identification of various parasitic species in clinical and research settings.
|
|
Europe, Asia-Pacific, and North America
|
In August 2018, Bruker announced the acquisition of German-based company Hain Life Science GmbH. It is a molecular diagnostic company. This will help in generating more revenue and Portfolio of the company and help in serving more customers.
|
|
4.
|
Thermo Fisher Scientific Inc.
|
Thermo Fisher Scientific is a prominent supplier of laboratory equipment and reagents for the Parasitology Identification Market. They offer a comprehensive range of products, including molecular assays, microscopy solutions, and culture media, facilitating accurate and efficient parasite detection in diverse sample types.
|
|
Europe, North America, South America, Middle East and Africa, and Asia-Pacific
|
In March 2020, Thermo Fisher Scientific Inc has launched Suretect PCR assays for the detection of pathogens. This will help in generating more revenue and Portfolio of the company and help in serving more customers.
|
|
5.
|
Quest Diagnostics Incorporated
|
Quest Diagnostics plays a significant role in the Parasitology Identification Market, offering a wide array of diagnostic tests and services for detecting parasitic infections. Their extensive network of laboratories and advanced testing capabilities support healthcare providers in diagnosing and managing parasitic diseases effectively.
|
|
U.S., Ireland, India, and Mexico
|
In October 2013, Quest diagnostics have announced the acquire converge diagnostics, which is a known diagnostic firm. This will help in generating more revenue and Portfolio of the company and helped in serving more customers.
|
Conclusion
In the parasitology identification market, companies like BIOMÉRIEUX, Abbott, Bruker, Thermo Fisher Scientific Inc., and Quest Diagnostics Incorporated play pivotal roles in advancing diagnostic technologies for detecting parasitic infections. Their innovative solutions, ranging from molecular assays to mass spectrometry-based systems, empower healthcare providers with accurate and timely identification of parasites. By offering a comprehensive portfolio of products and services, these companies contribute significantly to improving patient outcomes and enhancing public health efforts worldwide. Their ongoing commitment to innovation underscores the importance of continued investment in parasitology identification for effective disease management and prevention.
